Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults. (22nd January 2019)
- Record Type:
- Journal Article
- Title:
- Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults. (22nd January 2019)
- Main Title:
- Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults
- Authors:
- Agbaji, Oche O.
Abah, Isaac O.
Ebonyi, Augustine O.
Gimba, Zumnan M.
Abene, Esla E.
Gomerep, Simji S.
Falang, Kakjing D.
Anejo-Okopi, Joseph
Agaba, Patricia A.
Ugoagwu, Placid O.
Agaba, Emmanuel I.
Imade, Godwin E.
Sagay, Atiene S.
Okonkwo, Prosper
Idoko, John A.
Kanki, Phyllis J. - Abstract:
- Objectives and Method: There are growing concerns of tenofovir disoproxil fumarate (TDF)–associated renal toxicity. We evaluated the effect of long-term TDF exposure on renal function in a cohort of HIV-1-infected Nigerians between 2006 and 2015. Multivariate logistic regression was used to identify predictors of renal impairment at different time over 144 weeks of antiretroviral therapy (ART). Results: Data of 4897 patients, median age 42 years (interquartile range: 36-49), and 61% females were analyzed. The prevalence of renal impairment increased from 10% at week 24 to 45% at 144 weeks in TDF-exposed participants compared to an increase from 8% at 24 weeks to 14% at 144 weeks in TDF-unexposed participants. Tenofovir disoproxil fumarate exposure predicted the risk of renal impairment at 144 weeks of ART (odds ratio: 2.36; 95% confidence interval: 1.28-4.34). Conclusion: Long-term exposure to TDF-based ART significantly increases the likelihood of renal impairment. The continued use of TDF-based regimen in our setting should be reviewed. We recommend the urgent introduction of tenofovir alafenamide–based regimen in the HIV treatment guidelines of Nigeria and other resource-limited countries.
- Is Part Of:
- Journal of the International Association of Providers of AIDS Care. Volume 18(2019)
- Journal:
- Journal of the International Association of Providers of AIDS Care
- Issue:
- Volume 18(2019)
- Issue Display:
- Volume 18, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 18
- Issue:
- 2019
- Issue Sort Value:
- 2019-0018-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-01-22
- Subjects:
- HIV -- ART -- tenofovir -- renal impairment -- Nigeria
AIDS (Disease) -- Periodicals
616.9792 - Journal URLs:
- http://jia.sagepub.com/ ↗
http://journals.sagepub.com/toc/JIA/current ↗
http://www.uk.sagepub.com ↗ - DOI:
- 10.1177/2325958218821963 ↗
- Languages:
- English
- ISSNs:
- 2325-9574
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12708.xml